CAR:ASXCAR Group Limited Analysis
Data as of 2026-08-31 - not real-time
A$27.65
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind CAR Group Limited is neutral at AUD 27.65, with no clear ordering between short and long averages. Over a rolling month the price has gained 7.6%. Relative strength is 47.9 — neutral — and the MACD signal is bearish. Price has been bracketed by support at AUD 25.90 and resistance at AUD 30.10.
Multiples put this in fair territory: 33.3 times earnings against the sector's 16.2. The average analyst target implies 20.5% above today's level. Revenue is growing at 3.8% on a 25.0% profit margin. The 3.16% dividend yield looks stretched against payout coverage.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 47.7%, a beta of 0.49 and a maximum drawdown of 44.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Multiples put this in fair territory: 33.3 times earnings against the sector's 16.2. The average analyst target implies 20.5% above today's level. Revenue is growing at 3.8% on a 25.0% profit margin. The 3.16% dividend yield looks stretched against payout coverage.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 47.7%, a beta of 0.49 and a maximum drawdown of 44.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Top Market Events
Investors were gobbling up CAR Group Ltd ASX: CAR shares yesterday after the company released FY26 results.What is Ord Minnett saying about CAR Group Limited ASX: CAR , Judo Capital Holdings Ltd ASX: JDO , and Worley Ltd ASX:...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 27.28
- MACD momentum is negative
- 30-day price change of +7.6%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 33.3 versus sector average of 16.2
- Dividend yield of 3.16% looks stretched against payout coverage
- Trading above the 200-day average of 27.28
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 33.3 versus sector average of 16.2
- Dividend yield of 3.16% looks stretched against payout coverage
- Analyst targets imply +20.5% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth3.80%
Profit Margin25.03%
P/E Ratio33.3
ROE11.34%
ROA6.15%
Debt/Equity57.03
P/B Ratio3.8
Op. Cash FlowA$577.2M
Free Cash FlowA$399.9M
Industry P/E16.2
Technical Analysis
TrendNeutral
RSI47.9
SupportA$25.90
ResistanceA$30.10
MA 20A$28.52
MA 50A$26.90
MA 200A$27.28
MACDBearish
VolumeIncreasing
Fear & Greed Index93.93
Valuation
Fair ValueA$12.57
Target PriceA$33.32
Upside/Downside20.51%
GradeFair
TypeBlend
Dividend Yield3.16%
Risk Assessment
Beta0.49
Volatility47.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.